Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luciano Mutti

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Expert Opinion on Emerging Drugs|June 26, 2009
Malignant pleural mesothelioma: current treatments and emerging drugsCarmen Belli, Dean Fennell, Monica Giovannini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
In arrayed ranks: array technology in the study of mesotheliomaSteven G Gray, Dean A Fennell, Luciano Mutti, et al.
Expert Opinion on Investigational Drugs|July 3, 2013
Therapies currently in Phase II trials for malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Daniela Tavian, et al.
Biochimica Et Biophysica Acta|August 10, 2015
The role of microenvironment and immunity in drug response in leukemiaEmyr Bakker, Malak Qattan, Luciano Mutti, et al.
Plos One|May 17, 2012
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Giovanni Angeli, et al.
Frontiers in Pharmacology|January 3, 2022
A Glimpse in the Future of Malignant Mesothelioma TreatmentGaetano Pezzicoli, Mimma Rizzo, Martina Perrone, et al.
Frontiers in Immunology|March 31, 2023
Intratumor microbiota as a novel potential prognostic indicator in mesotheliomaFrancesca Pentimalli, Marija Krstic-Demonacos, Caterina Costa, et al.
Frontiers in Immunology|October 31, 2025
Correction: Intratumor microbiota as a novel potential prognostic indicator in mesotheliomaFrancesca Pentimalli, Marija Krstic-Demonacos, Caterina Costa, et al.
Biomarker Research|January 17, 2023
The function and clinical implication of YTHDF1 in the human system development and cancerWenjun Ren, Yixiao Yuan, Yongwu Li, et al.
European Journal of Case Reports in Internal Medicine|January 10, 2025
Hepatic Sinusoidal Obstruction Syndrome (SOS) Associated with Checkpoint Inhibitor TherapyMarianna Litterio, Nicole Marchetti, Francesco Carubbi, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Expert Opinion on Emerging Drugs|June 26, 2009
Malignant pleural mesothelioma: current treatments and emerging drugsCarmen Belli, Dean Fennell, Monica Giovannini, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
In arrayed ranks: array technology in the study of mesotheliomaSteven G Gray, Dean A Fennell, Luciano Mutti, et al.
Expert Opinion on Investigational Drugs|July 3, 2013
Therapies currently in Phase II trials for malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Daniela Tavian, et al.
Biochimica Et Biophysica Acta|August 10, 2015
The role of microenvironment and immunity in drug response in leukemiaEmyr Bakker, Malak Qattan, Luciano Mutti, et al.
Plos One|May 17, 2012
Perifosine as a potential novel anti-cancer agent inhibits EGFR/MET-AKT axis in malignant pleural mesotheliomaGiulia Pinton, Arcangela Gabriella Manente, Giovanni Angeli, et al.
Frontiers in Pharmacology|January 3, 2022
A Glimpse in the Future of Malignant Mesothelioma TreatmentGaetano Pezzicoli, Mimma Rizzo, Martina Perrone, et al.
Frontiers in Immunology|March 31, 2023
Intratumor microbiota as a novel potential prognostic indicator in mesotheliomaFrancesca Pentimalli, Marija Krstic-Demonacos, Caterina Costa, et al.
Frontiers in Immunology|October 31, 2025
Correction: Intratumor microbiota as a novel potential prognostic indicator in mesotheliomaFrancesca Pentimalli, Marija Krstic-Demonacos, Caterina Costa, et al.
Biomarker Research|January 17, 2023
The function and clinical implication of YTHDF1 in the human system development and cancerWenjun Ren, Yixiao Yuan, Yongwu Li, et al.
European Journal of Case Reports in Internal Medicine|January 10, 2025
Hepatic Sinusoidal Obstruction Syndrome (SOS) Associated with Checkpoint Inhibitor TherapyMarianna Litterio, Nicole Marchetti, Francesco Carubbi, et al.
Pageof 13